Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: A multicenter study from Southern Sweden

Endocrine

Volumn 42, Issue 1, 2012, Pages 164-173

  Olsen, Henrik ^d   Nordenström, Erik ^a   Bergenfelz, Anders ^a   Nyman, Ulf ^b   Valdemarsson, Stig ^a   Palmqvist, Erik ^c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Hospital of Trelleborg   (Sweden)

^c HALMSTAD HOSPITAL   (Sweden)

^d HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Adrenal CT; Adrenal imaging; Adrenal incidentaloma; Houndsfield units; Subclinical Cushing syndrome; Subclinical hypercortisolism

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; BILATERAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCORTISOLISM; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SUBCLINICAL HYPERCORTISOLISM; SWEDEN; TUMOR VOLUME;

EID: 84864967238     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9622-2     Document Type: Article

References (33)

1. S. Bovio, A. Cataldi, G. Reimondo, P. Sperone, S. Novello, A. Berruti, P. Borasio, C. Fava, L. Dogliotti, G.V. Scagliotti, A. Angeli, M. Terzolo, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29(4), 298-302 (2006)
2. R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16(4), 460-484 (1995)
3. W.F. Young Jr, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356(6), 601-610 (2007). doi:10.1056/NEJMcp065470
4. F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A. Angeli, A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85(2), 637-644 (2000)
5. B. Bulow, B. Ahren, Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J. Intern. Med. 252(3), 239-246 (2002)
6. J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190(5), 1163-1168 (2008). doi:10.2214/AJR.07.2799
7. S. Tsagarakis, D. Vassiliadi, N. Thalassinos, Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J. Endocrinol. Invest. 29(5), 471-482 (2006)
8. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93(5), 1526-1540 (2008). doi:10.1210/jc.2008-0125
9. G.P. Piaditis, G.A. Kaltsas, I.I. Androulakis, A. Gouli, P. Makras, D. Papadogias, K. Dimitriou, D. Ragkou, A. Markou, K. Vamvakidis, G. Zografos, G. Chrousos, High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin. Endocrinol. (Oxf.) 71(6), 772-778 (2009). doi:10.1111/j.1365-2265.2009.03551.x
10. E. Vassilatou, A. Vryonidou, S. Michalopoulou, J. Manolis, J. Caratzas, C. Phenekos, I. Tzavara, Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin. Endocrinol. (Oxf.) 70(5), 674-679 (2009). doi:10.1111/j.1365-2265.2008.03492.x
11. I. Chiodini, Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin. Endocrinol. Metab. 96(5), 1223-1236 (2011). doi:10.1210/jc.2010-2722
12. G.G. Garrapa, P. Pantanetti, G. Arnaldi, F. Mantero, E. Faloia, Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. J. Clin. Endocrinol. Metab. 86(11), 5301-5306 (2001)
13. L. Tauchmanova, R. Rossi, B. Biondi, M. Pulcrano, V. Nuzzo, E.A. Palmieri, S. Fazio, G. Lombardi, Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. J. Clin. Endocrinol. Metab. 87(11), 4872-4878 (2002)
14. M. Terzolo, A. Pia, A. Ali, G. Osella, G. Reimondo, S. Bovio, F. Daffara, M. Procopio, P. Paccotti, G. Borretta, A. Angeli, Adrenal incidentaloma: a new cause of the metabolic syndrome? J. Clin. Endocrinol. Metab. 87(3), 998-1003 (2002)
15. I. Chiodini, V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, R. Viti, F. Coletti, G. Guglielmi, C. Battista, V. Carnevale, L. Iorio, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J. Clin. Endocrinol. Metab. 94(9), 3207-3214 (2009). doi:10.1210/jc.2009-0468
16. G. Bernini, A. Moretti, P. Iacconi, P. Miccoli, R. Nami, B. Lucani, A. Salvetti, Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur. J. Endocrinol. 148(2), 213-219 (2003)
17. I. Chiodini, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, F. Pellegrini, M. Copetti, P. Beck-Peccoz, M. Arosio, B. Ambrosi, V. Trischitta, A. Scillitani, Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J. Clin. Endocrinol. Metab. 95(6), 2736-2745 (2010). doi:10.1210/jc.2009-2387
18. A. Toniato, I. Merante-Boschin, G. Opocher, M.R. Pelizzo, F. Schiavi, E. Ballotta, Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann. Surg. 249(3), 388-391 (2009). doi:10.1097/SLA.0b013e31819a47d2
19. M. Korobkin, T.J. Giordano, F.J. Brodeur, I.R. Francis, E.S. Siegelman, L.E. Quint, N.R. Dunnick, J.P. Heiken, H.H. Wang, Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200(3), 743-747 (1996)
20. D.H. Szolar, M. Korobkin, P. Reittner, A. Berghold, T. Bauernhofer, H. Trummer, H. Schoellnast, K.W. Preidler, H. Samonigg, Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234(2), 479-485 (2005). doi:10.1148/radiol. 2342031876
21. M.A. Blake, C.G. Cronin, G.W. Boland, Adrenal imaging. AJR Am. J. Roentgenol. 194(6), 1450-1460 (2010). doi:10.2214/AJR.10.4547
22. L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macri, M. Boscaro, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 83(1), 55-62 (1998)
23. D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (2010). doi:10.1111/j.1365-2265. 2010.03963.x
24. S. Tsagarakis, P. Kokkoris, C. Roboti, C. Malagari, J. Kaskarelis, V. Vlassopoulou, C. Alevizaki, N. Thalassinos, The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clin. Endocrinol. (Oxf.) 48(5), 627-633 (1998)
25. M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J Endocrinol./Eur. Fed. Endocr. Soc. 164(6), 851-870 (2011). doi:10.1530/EJE-10-1147
26. M. Terzolo, A. Pia, G. Reimondo, Subclinical Cushing's syndrome: definition and management. Clin. Endocrinol. 76(1), 12-18 (2012). doi:10.1111/j.1365-2265.2011.04253.x
27. V. Morelli, B. Masserini, A.S. Salcuni, C. Eller-Vainicher, C. Savoca, R. Viti, F. Coletti, G. Guglielmi, C. Battista, L. Iorio, P. Beck-Peccoz, B. Ambrosi, M. Arosio, A. Scillitani, I. Chiodini, Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clin. Endocrinol. (Oxf.) 73(2), 161-166 (2010). doi:10.1111/j.1365-2265.2010.03794.x
28. S. Tsagarakis, C. Roboti, P. Kokkoris, V. Vasiliou, C. Alevizaki, N. Thalassinos, Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas. Clin. Endocrinol. (Oxf.) 49(2), 165-171 (1998)
29. S. Bujawansa, D. Bowen-Jones, Low investigation rate for adrenal incidentalomas. Endocrine 40(1), 134-136 (2011). doi:10.1007/s12020-011-9487-9
30. L. Barzon, F. Fallo, N. Sonino, M. Boscaro, Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas. Eur. J. Endocrinol. 145(2), 223-224 (2001)
31. A. Comlekci, S. Yener, S. Ertilav, M. Secil, B. Akinci, T. Demir, L. Kebapcilar, F. Bayraktar, S. Yesil, S. Eraslan, Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1), 40-46 (2010). doi:10.1007/s12020-009-9260-5
32. D.A. Vassiliadi, G. Ntali, T. Stratigou, M. Adali, S. Tsagarakis, Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas. Endocrine 40(3), 437-444 (2011). doi:10.1007/s12020-011-9490-1
33. J. Majnik, A. Patocs, K. Balogh, M. Toth, P. Gergics, A. Szappanos, A. Mondok, G. Borgulya, P. Panczel, Z. Prohaszka, K. Racz, Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas. J. Clin. Endocrinol. Metab. 91(7), 2796-2799 (2006). doi:10.1210/jc.2006-0066